GlaxoSmithKline(GSK)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE 100

Market Cap

£66,430m

Change Today

Price Down-8.00p

Share Price

1,270.00p

Sector movers: Pharmas on a high after Astra victory

Date: Wednesday 02 Jul 2008

LONDON (ShareCast) - The pharmaceuticals sector was given a shot in the arm after AstraZeneca triumphed its legal battle against two companies that want to market generic versions of its Seroquel schizophrenia treatment. Astra and its fellow drug giant GlaxoSmithKline were among the best performing companies in the FTSE 100.

General retailers and food retailers are down after Marks and Spencer’s first quarter UK like for like sales fell 5.3% and it warned that tough conditions are here to stay for two years. M&S lost more than 20% of its value and dragged down fellow clothes retailer Next and fellow food retailers J Sainsbury, Tesco and Wm Morrison.

Also in the retail sector, B&Q owner Kingfisher fell heavily after cement and aggregates supplier Ennstone issued a profit warning that alluded to the continued deterioration in the US market and recent sharp downturn in UK house building activity.

Top performing sectors so far today
Pharmaceuticals & Biotechnology 7,357.10 +4.33%
Mobile Telecommunications 3,478.00 +3.49%
Fixed Line Telecommunications 2,746.40 +2.83%
Life Insurance 3,953.00 +2.48%

Bottom performing sectors so far today
General Retailers 1,154.90 -7.74%
Automobiles & Parts 3,132.40 -4.11%
Food & Drug Retailers 4,042.60 -3.92%
Electronic & Electrical Equipment 1,849.70 -3.14%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,270.00p Price Down
Change Today -8.00p
52 Week High 1,385.00
52 Week Low 1,001.00
Volume 16,417,444
Shares Issued 5,231m
Market Cap £66,430m
Beta 0.58
RiskGrade 120

Performance Indicators

Compare performance with the sector and the market.
Find out more
Key: vs Market vs Sector
Value
68.9% below the market average68.9% below the market average68.9% below the market average68.9% below the market average68.9% below the market average
50.62% above the sector average50.62% above the sector average50.62% above the sector average50.62% above the sector average50.62% above the sector average
Price Trend
57.72% above the market average57.72% above the market average57.72% above the market average57.72% above the market average57.72% above the market average
66.29% above the sector average66.29% above the sector average66.29% above the sector average66.29% above the sector average66.29% above the sector average
Income
23.20% above the market average23.20% above the market average23.20% above the market average23.20% above the market average23.20% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
64.07% below the market average64.07% below the market average64.07% below the market average64.07% below the market average64.07% below the market average
80.56% below the sector average80.56% below the sector average80.56% below the sector average80.56% below the sector average80.56% below the sector average
Price Chg 6m
87.17% above the market average87.17% above the market average87.17% above the market average87.17% above the market average87.17% above the market average
77.53% above the sector average77.53% above the sector average77.53% above the sector average77.53% above the sector average77.53% above the sector average
P/E
7.92% below the market average7.92% below the market average7.92% below the market average7.92% below the market average7.92% below the market average
44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average
PEG Not Available
Dividend Yield
12.50% above the market average12.50% above the market average12.50% above the market average12.50% above the market average12.50% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
EPS Growth Not Available
Operating Margin
58.69% above the market average58.69% above the market average58.69% above the market average58.69% above the market average58.69% above the market average
97.37% above the sector average97.37% above the sector average97.37% above the sector average97.37% above the sector average97.37% above the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 14
Sell 7
Strong Sell 3
Total 31
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 30-Jul-08 30-Apr-08
Paid 09-Oct-08 10-Jul-08
Amount 13.00p 13.00p

Trades for 05-Sep-2008

Time Volume / Share Price
12:08 9,990 @ 1,278.66p
16:57 51,106 @ 1,282.43p
16:56 8,854 @ 1,277.79p
16:35 7,881 @ 1,269.36p
16:48 95,000 @ 1,278.53p

GlaxoSmithKline Key Personnel

CEO Jean-Pierre Garnier
CFO Julian Heslop
Chair Moncef Slaoui

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).